An observational study in Arthroplasty and Total Hip Replacement, sponsored by Seoul National University Bundang Hospital. Completed at 1 site in Korea, Republic of. Per ClinicalTrials.gov, last updated 2016-03-29.
Sponsored by Seoul National University Bundang Hospital · Observational
The purpose of this study was to develop a radiological method to measure stem anteversion and to determine its validity and reliability.
Version of the femoral stem is an important factor influencing the risk of dislocation after total hip replacement (THR) as well as the position of the acetabular component. However, there is no radiological method of measuring stem anteversion described in the literature. Investigators propose a radiological method to measure stem version and have assessed its reliability and validity. In 40 patients who underwent THR, a hip radiograph and CT scan were taken to measure stem anteversion.
Seoul National University Bundang Hospital is the lead sponsor of 368 studies on the registry; 55 are open to participants now.
Counted across the registry records on this site, refreshed daily.
patients who underwent THR between October 2015 and December 2015
Exclusion Criteria:
a hip lateral radiograph and CT scan were taken to measure stem anteversion
Radiation: Radiological measurement of femoral stem version
particular radiographs( lateral decubitus view) and CT scans
stem anteversion of the hip radiograph(decubitus lateral view)
Time frame: postoperative 4days
stem anteversion of the CT scan
Time frame: postoperative 4days
The correlation between stem anteversion of the decubitus lateral view and stem version of the CT scan
to determine ICC(intraclass coefficient, correlation coefficient)
Time frame: postoperative 4days
This study is completed, as verified in Mar 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Seoul National University Bundang Hospital